Rare diseases
Investigational molecules
Locations
469 conditions with trials, the busiest first
1 123 trials across Europe, recruiting first
One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease
FranceAn observational study on the use of methotrexate in children and adolescents with Crohn's disease
The NetherlandsA Study Comparing PF-08634404 and a Drug Combination with Chemotherapy in Adults with Metastatic Colorectal Cancer
BelgiumSafety of injecting bupivacaine and dexamethasone into the parotid gland for patients undergoing surgery for a benign parotid tumor
FranceStudy of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis
BelgiumA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
AustriaA study of irinotecan and a drug combination for patients with gastric cancer or gastroesophageal junction cancer undergoing surgery.
The NetherlandsA study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer
FranceA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
AustriaA long-term safety study of KYV-101 in patients previously treated for lupus nephritis, systemic sclerosis, myasthenia gravis, rheumatoid arthritis, or stiff person syndrome
GermanyUsing 68Ga-FAPI-46 imaging to detect fibrosis in patients with inflammatory diseases such as Crohn's disease, ulcerative colitis, systemic sclerosis, and lung fibrosis.
The NetherlandsStudy of the safety and use of the Extroducer infusion catheter system for delivering gemcitabine to patients with unresectable locally advanced pancreatic cancer
SwedenThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
